<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01435707</url>
  </required_header>
  <id_info>
    <org_study_id>2011-08-058</org_study_id>
    <nct_id>NCT01435707</nct_id>
  </id_info>
  <brief_title>The Effect of Epidural Steroid Injections on Glycemic Control in Diabetic Patients According to the Doses of Steroids</brief_title>
  <official_title>The Effect of Epidural Steroid Injections on Glycemic Control in Diabetic Patients According to the Doses of Steroids</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There has been no reports of the effect of various kinds of steroid or various dose of
      steroid which are commonly used in the clinical setting. Previous studies have simply shown
      that the blood glucose level is elevated in diabetes patients and did not show or suggest the
      adequate strategy of epidural steroid injection in diabetes patients regarding steroid type,
      dosage or injection interval. Therefore, the investigators tried to evaluate the effect of
      different dosage of triamcinolone, which is a commonly used steroid in epidural steroid
      injection, on the blood glucose level.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is well known that blood glucose level is elevated in diabetes patients more than
      non-diabetes patients who underwent the epidural steroid injection. However, there has been
      no reports of the effect of various kinds of steroid or various dose of steroid which are
      commonly used in the clinical setting. Previous studies have simply shown that the blood
      glucose level is elevated in diabetes patients and did not show or suggest the adequate
      strategy of epidural steroid injection in diabetes patients regarding steroid type, dosage or
      injection interval. Therefore, the investigators tried to evaluate the effect of different
      dosage of triamcinolone, which is a commonly used steroid in epidural steroid injection, on
      the blood glucose level.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>fasting blood glucose level</measure>
    <time_frame>at 7:00 am of postprocedure day 1</time_frame>
    <description>before breakfast (fasting state)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>fasting blood glucose level</measure>
    <time_frame>at 7:00 am of postprocedure day 2</time_frame>
    <description>before breakfast (fasting state)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>fasting blood glucose level</measure>
    <time_frame>at 7:00 am of postprocedure day 3</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>fasting blood glucose level</measure>
    <time_frame>at 7:00 am of postprocedure day 4</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>fasting blood glucose level</measure>
    <time_frame>at 7:00 am of postprocedure day 5</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>fasting blood glucose level</measure>
    <time_frame>at 7:00 am of postprocedure day 6</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>fasting blood glucose level</measure>
    <time_frame>at 7:00 am of postprocedure day 7</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>fasting blood glucose</measure>
    <time_frame>at 7:00 am of postprocedure day 14</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>post-prandial glucose level</measure>
    <time_frame>2 hour after dinner at postprandial day 1, 2, 3, 4, 5, 6, 7, 14</time_frame>
    <description>2 hour after dinner</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>visual analogue scale of subjective pain</measure>
    <time_frame>at 7 p.m. of postprocedure day 1, 2, 3, 4, 5, 6, 7, 14</time_frame>
    <description>at 7:00 am of postprocedure day 5</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">125</enrollment>
  <condition>Low Back Pain</condition>
  <arm_group>
    <arm_group_label>Caudal 40 group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects who undergo caudal epidural block with triamcinolone 40 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>STE 20 group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects who undergo selective transforaminal block with triamcinolone 20 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Caudal 20 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects who undergo caudal epidural block with triamcinolone 20 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>STE 40 group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects who undergo selective transforaminal block with triamcinolone 40 mg</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>epidural steroid injection with Triamcinolone 40mg</intervention_name>
    <description>epidural steroid injection with Triamcinolone 40mg</description>
    <arm_group_label>Caudal 40 group</arm_group_label>
    <other_name>Triamcinolone</other_name>
    <other_name>epidural steroid injection</other_name>
    <other_name>caudal epidural block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Selective transforaminal epidural block with triamcinolone 20 mg</intervention_name>
    <description>Selective transforaminal epidural block with triamcinolone 20 mg</description>
    <arm_group_label>STE 20 group</arm_group_label>
    <other_name>selective transforaminal block</other_name>
    <other_name>Triamcinolone</other_name>
    <other_name>epidural steroid injection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>caudal epidural steroid injection with Triamcinolone 20mg</intervention_name>
    <description>caudal epidural steroid injection with Triamcinolone 20mg</description>
    <arm_group_label>Caudal 20 mg</arm_group_label>
    <other_name>Triamcinolone</other_name>
    <other_name>epidural steroid injection</other_name>
    <other_name>caudal epidural block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Selective transforaminal epidural block with triamcinolone 40 mg</intervention_name>
    <description>Selective transforaminal epidural block with triamcinolone 40 mg</description>
    <arm_group_label>STE 40 group</arm_group_label>
    <other_name>selective transforaminal block</other_name>
    <other_name>Triamcinolone</other_name>
    <other_name>epidural steroid injection</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  subjects who undergo epidural steroid injection (caudal epidural injection or
             selective transforaminal block) in the pain medicine outpatient clinic

          -  subjects older than 20 yrs.

        Exclusion Criteria:

          -  ASA (American society of Anesthesiologists class) III or more

          -  severe cardiopulmonary disease or brain disorder

          -  Subjects diagnosed uncontrolled diabetes with complications

          -  subjects undergoing hormone therapy

          -  subjects with active infection

          -  subjects with pregnancy

          -  subjects with recent stress condition such as surgery or trauma

          -  subjects with active neurologic disorder

          -  those with anticoagulation therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 15, 2011</study_first_submitted>
  <study_first_submitted_qc>September 16, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2011</study_first_posted>
  <last_update_submitted>December 24, 2013</last_update_submitted>
  <last_update_submitted_qc>December 24, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>Woo Seog Sim</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>epidural steroid injection</keyword>
  <keyword>triamcinolone</keyword>
  <keyword>fasting blood glucose</keyword>
  <keyword>diabetes mellitus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Triamcinolone hexacetonide</mesh_term>
    <mesh_term>Triamcinolone</mesh_term>
    <mesh_term>Triamcinolone Acetonide</mesh_term>
    <mesh_term>Triamcinolone diacetate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

